Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Primary Prevention of Coronary Heart Disease: Challenges and Achievements

02.09.2008
ESC CONGRESS 2008 - New Strategies in Prevention

Lifestyle and risk factor results clearly demonstrate a challenging gap between what is recommended in scientific guidelines and what is achieved in daily practice in high risk individuals in primary prevention of CVD.

Primary prevention needs a comprehensive, multidisciplinary approach involving the high-risk population, their GP’s and other health professionals, a health insurance system dedicated to prevention and all this complemented by a population strategy involving the community at large.

The European Society of Cardiology together with other partner Societies has engaged in a comprehensive programme of prevention of cardiovascular disease (CVD) since 1994. Guidelines on this important topic have been developed and updated at regular intervals over the last 13 years, most recently in 2007. The implementation of these guidelines is facilitated by the Joint European Prevention Committee and the new European Association for Cardiovascular Prevention and Rehabilitation through a network of national coordinators all over Europe.

Results are evaluated with audit surveys called EUROASPIRE starting in the mid-nineties with EUROASPIRE I, EUROASPIRE II at the turn of the millennium and EUROASPIRE III in 2006/07. This third EUROASPIRE survey has evaluated how effectively these recommendations have been implemented in daily practice in relation to the standards set in the Third Joint European Task Force guidelines on CVD prevention in 2003.

All three EUROASPIRE surveys have evaluated how patients with established CVD, who are the top clinical priority, are being managed, but in this third survey, the second priority group of asymptomatic individuals who are at high risk of developing CVD have been addressed. These apparently healthy individuals are at increased total CV risk because of markedly raised levels of blood pressure, cholesterol or the development of diabetes.

This “primary care arm” of EUROASPIRE III took place in 12 European countries in close collaboration with General Practitioners. Asymptomatic subjects, free of CVD, were identified and invited to participate if they fulfilled the following conditions:

Men and women aged Free of clinical CVD
Either started on drug therapy for arterial hypertension
On lipid lowering drugs or treated with diet
On hypoglycaemics or insuline because of type 2 diabetes for at least six months, but not more than three years prior to this study

Volunteers were seen by trained technicians for an interview and examination using standardised methods and central laboratory measurement of lipids and glucose.

A total of 4,366 individuals participated (78% of all eligible patients): 58% females, mean age approximately 60 years. 2,853 were on drug treatment for arterial hypertension, 1529 on lipid lowering drugs and 1,031 were treated for type 2 diabetes.

Smoking of tobacco was still prevalent in 16.5% of all subjects, even in 30% of men = 25 Kg/m2) and most were centrally obese as well.

Blood pressure was not within guideline recommended limits (BP
Among all individuals treated with lipid lowering drugs and/or with a total cholesterol of >= 4.5 mmol/l, only 31% was on target according to the guidelines. Among all subjects treated for type 2 diabetes, fasting glycaemia was

These lifestyle and risk factor results clearly demonstrate a challenging gap between what is recommended in the guidelines based on scientific evidence and what is achieved in daily practice in high risk individuals in primary prevention of CVD. Primary prevention needs a comprehensive, multidisciplinary approach involving the high-risk population, their GP’s and other health professionals, a health insurance system dedicated to prevention and all this complemented by a population strategy involving the community at large.

Jacqueline Partarrieu | alfa
Further information:
http://www.escardio.org

More articles from Event News:

nachricht 10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018
08.01.2018 | Haus der Technik e.V.

nachricht See, understand and experience the work of the future
11.12.2017 | Fraunhofer-Institut für Arbeitswirtschaft und Organisation IAO

All articles from Event News >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

Im Focus: A thermometer for the oceans

Measurement of noble gases in Antarctic ice cores

The oceans are the largest global heat reservoir. As a result of man-made global warming, the temperature in the global climate system increases; around 90% of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Polymers Based on Boron?

18.01.2018 | Life Sciences

Bioengineered soft microfibers improve T-cell production

18.01.2018 | Life Sciences

World’s oldest known oxygen oasis discovered

18.01.2018 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>